Federico Mingozzi

2.2k citations

31 papers · 1.5k indexed · h-index 19

Genetics top 2%
- Virus-based gene therapy research 21
- Neurogenetic and Muscular Disorders Research 3
Oncology top 10%
- CAR-T cell therapy research 11
Molecular Biology top 10%
- RNA Interference and Gene Delivery 6
- CRISPR and Genetic Engineering 5
- Viral Infectious Diseases and Gene Expression in Insects 3
Physiology top 10%
- Lysosomal Storage Disorders Research 11
- Adenosine and Purinergic Signaling 3
Genetics top 10%
- Virus-based gene therapy research 21
- Neurogenetic and Muscular Disorders Research 3

Co-authors: Katherine A. High Daniel J. Hui Etiena Basner‐Tschakarjan Christian Hinderer Roland W. Herzog P. Véron Virginia Haurigot Gregory M. Podsakoff
Cited by: Genetics Oncology Molecular Biology
Partner nations: United States France Spain

In The Last Decade

Federico Mingozzi

30 papers receiving 1.5k citations

Peers

Countries citing papers authored by Federico Mingozzi

Since Specialization

Citations

This map shows the geographic impact of Federico Mingozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Mingozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Mingozzi more than expected).

Fields of papers citing papers by Federico Mingozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Mingozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Mingozzi. The network helps show where Federico Mingozzi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Federico Mingozzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Federico Mingozzi Line = papers co-authored together Federico Mingozzi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice Michela Lisjak,Alessia De Caneva,Thibaut Marais,Elena Barbon,Maria Grazia Biferi,Fabiola Porro,Adi Barzel,Lorena Zentilin,Mark A. Kay,Federico Mingozzi,Andrés F. Muro	2022	16
2	Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects Pasqualina Colella,Pauline Sellier,Manuel J. Gómez,Maria Grazia Biferi,Guillaume Tanniou,Nicolas Guerchet,Mathilde Cohen-Tannoudji,Maryse Moya‐Nilges,Laetitia van Wittenberghe,Nathalie Danièle,Bernard Gjata,Jacomina Krijnse‐Locker,Fanny Collaud,Marcelo Simon‐Sola,Séverine Charles,Umut Cagin,Federico Mingozzi	2020	18
3	Gene Therapy for Pompe Disease: The Time is now Pasqualina Colella,Federico Mingozzi	2019	18
4	Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle Jérôme Poupiot,Helena Costa Verdera,Romain Hardet,Pasqualina Colella,Fanny Collaud,Laurent Bartolo,Jean Davoust,Peggy Sanatine,Federico Mingozzi,Isabelle Richard,Giuseppe Ronzitti	2019	19
5	Exposure to wild-type AAV drives distinct capsid immunity profiles in humans Klaudia Kuranda,Priscilla Jean-Alphonse,Christian Leborgne,Romain Hardet,Fanny Collaud,Solenne Marmier,Helena Costa Verdera,Giuseppe Ronzitti,P. Véron,Federico Mingozzi	2018	78
6	Interim Analysis of Immunogenicity to the Vector Capsid and Transgene-Expressed Human FVIII in a Phase-1/2 Clinical Study of Bmn 270, an AAV5-Mediated Gene Therapy for Hemophilia a Brian Long,Benjamin Kim,Wing Yen Wong,Kehu Yang,Christian Vettermann,Nancy Pryer,Romain Hardet,Klaudia Kuranda,P. Véron,Federico Mingozzi,Glenn F. Pierce,Becky Schweighardt	2017	1
7	Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction Sang-oh Han,Giuseppe Ronzitti,Benjamin Arnson,Christian Leborgne,Songtao Li,Federico Mingozzi,Dwight D. Koeberl	2017	60
8	Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenes Pasqualina Colella,Francesco Puzzo,Maria Grazia Biferi,Deeksha Bali,Nicole K. Paulk,Pierre Vidal,Fanny Collaud,Marcelo Simon‐Sola,Séverine Charles,Romain Hardet,Christian Leborgne,Pauline Sellier,Laetitia van Wittenberghe,Florence Boisgérault,M. Barkats,Pascal Laforêt,Mark A. Kay,Dwight D. Koeberl,Giuseppe Ronzitti,Federico Mingozzi	2017	1
9	The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer Florence Boisgérault,Federico Mingozzi	2015	40
10	Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System Amine Meliani,Christian Leborgne,Sabrina Triffault,Laurence Jeanson-Leh,P. Véron,Federico Mingozzi	2015	86
11	Innate and Adaptive Immune Response in Fabry Disease Wladimir Mauhin,Olivier Lidove,Elisa Masat,Federico Mingozzi,K. Mariampillai,Jean-Marc Ziza,Olivier Benvéniste	2015	68
12	AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes Daniel J. Hui,Shyrie C Edmonson,Gregory M. Podsakoff,Gary C. Pien,Lacramioara Ivanciu,Rodney M. Camire,Hildegund C.J. Ertl,Federico Mingozzi,Katherine A. High,Etiena Basner‐Tschakarjan	2015	67
13	Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis Yves Allenbach,Wahiba Chaara,Michèlle Rosenzwajg,Adrien Six,Nicolas Prevel,Federico Mingozzi,Julia Wanschitz,Lucile Musset,Jean‐Luc Charuel,B. Eymard,Benoı̂t L. Salomon,Charles Duyckaerts,Thierry Maisonobe,O. Dubourg,S. Herson,David Klatzmann,Olivier Benvéniste	2014	61
14	Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy Virginia Haurigot,Sara Marcó,Albert Ribera,Miquel García,Albert Ruzo,Pilar Villacampa,Eduard Ayuso,Sònia Añor,Anna Andaluz,Mercédes Pineda,Gemma García‐Fructuoso,Maria Molas,Luca Maggioni,Sergio Muñoz,Sandra Motas,Jesús Ruberte,Federico Mingozzi,Martı́ Pumarola,Fátima Bosch	2013	176
15	Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG? Anne S. De Groot,Leslie P. Cousens,Federico Mingozzi,William J. Martin	2013	21
16	Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes Daniel J. Hui,Etiena Basner‐Tschakarjan,Yifeng Chen,Robert J. Davidson,George Buchlis,Mustafa N. Yazicioglu,Gary C. Pien,Jonathan D. Finn,Virginia Haurigot,Alex Tai,David W. Scott,Leslie P. Cousens,Shangzhen Zhou,Anne S. De Groot,Federico Mingozzi	2013	39
17	IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression Irene Gil-Fariña,Marianna Di Scala,Lucía Vanrell,Cristina Olagüe,África Vales,Katherine A. High,Jesús Prìeto,Federico Mingozzi,Gloria González‐Aseguinolaza	2013	18
18	Teaching tolerance Leslie P. Cousens,Federico Mingozzi,Sander van der Marel,Yan Su,Richard D. Garman,Valérie Ferreira,William Martin,David W. Scott,Anne S. De Groot	2012	15
19	Identification of mouse AAV capsid-specific CD8+ T cell epitopes Denise E. Sabatino,Federico Mingozzi,Daniel J. Hui,Haifeng Chen,Peter Colosi,Hildegund C.J. Ertl,Katherine A. High	2005	76
20	Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9 Paul Fields,Valder R. Arruda,Elina Armstrong,Kirk Chu,Federico Mingozzi,J. Nathan Hagstrom,Roland W. Herzog,Katherine A. High	2001	107

About Federico Mingozzi

Federico Mingozzi is a scholar working on Genetics, Physiology and Physiology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (11 papers), Lysosomal Storage Disorders Research (11 papers), RNA Interference and Gene Delivery (6 papers), CRISPR and Genetic Engineering (5 papers), Adenosine and Purinergic Signaling (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). The work is most often cited by research in Genetics (1.0k citations), Oncology (391 citations) and Molecular Biology (918 citations). Federico Mingozzi has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Katherine A. High, Daniel J. Hui, Etiena Basner‐Tschakarjan, Christian Hinderer, Roland W. Herzog, P. Véron, Virginia Haurigot, Gregory M. Podsakoff, Florence Boisgérault and Sara Marcó.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact